All Stories

  1. Synthesis, Molecular Docking Studies and Biological Evaluation of N-(α-benzamido cinnamoyl) Piperonal Hydrazones
  2. In silico trials to design potent inhibitors against matrilysin (MMP-7)
  3. In silico exploration of lignin peroxidase for unraveling the degradation mechanism employing lignin model compounds
  4. Design, synthesis, anti-tobacco mosaic viral and molecule docking simulations of urea/thiourea derivatives of 2-(piperazine-1-yl)-pyrimidine and 1-(4-Fluoro/4-Chloro phenyl)-piperazine and 1-(4-Chloro phenyl)-piperazine – A study
  5. Novel and potent inhibitors for dihydropteroate synthase ofHelicobacter pylori
  6. Synthesis, Molecular Docking Studies and Biological Evaluation of N-Acylarylhydrazones as Anti-Inflammatory Agents
  7. Integration of core hopping, quantum-mechanics, molecular mechanics coupled binding-energy estimations and dynamic simulations for fragment-based novel therapeutic scaffolds against Helicobacter pylori strains
  8. In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains
  9. An in silico approach towards identification of novel drug targets in pathogenic species of Leptospira
  10. Hierarchical-Clustering, Scaffold-Mining Exercises and Dynamics Simulations for Effectual Inhibitors Against Lipid-A Biosynthesis of Helicobacter pylori
  11. Design of Novel Antimycobacterial Molecule Targeting Shikimate Pathway of Mycobacterium tuberculosis
  12. Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study
  13. Epitope-driven common subunit vaccine design against H. pylori strains
  14. In silico Prediction, Characterization, Molecular Docking, and Dynamic Studies on Fungal SDRs as Novel Targets for Searching Potential Fungicides Against Fusarium Wilt in Tomato
  15. An in silico study: Novel targets for potential drug and vaccine design against drug resistant H. pylori
  16. Synthesis, Biological Evaluation and Docking Studies of N-(2-benzamido feruloyl) Aryl Hydrazone Analogues
  17. Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations
  18. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors
  19. In Silico Approach to Support that p-Nitrophenol Monooxygenase from Arthrobacter sp. Strain JS443 Catalyzes the Initial Two Sequential Monooxygenations
  20. E-Pharmacophore Based Virtual Screening to Identify Agonist for PKA-Cα
  21. Synthesis, biological evaluation, and molecular docking studies of N-(α-acetamido cinnamoyl) aryl hydrazone derivatives as antiinflammatory and analgesic agents
  22. Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis
  23. Computational approaches to identify common subunit vaccine candidates against bacterial meningitis
  24. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC ofLeptospiraspp.: homology modeling, docking, and molecular dynamics study
  25. In silico design of potent agonists for human PPAR γ
  26. Computer aided subunit vaccine design against pathogenic Leptospira serovars
  27. Unrestricted Vision
  28. In silico design of novel leads for inhibition of human beta-2-microglobulin
  29. In-silico analysis of human IGFBP-4 involved in cardiovascular diseases
  30. Mizoribin as a inhibitor for leukocyte immunoglobulin receptor sub family A member3
  31. Docking-based virtual screening for the exploration of potential antagonists for human IGFBP6
  32. Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus
  33. Para-(benzoyl)-phenylalanine as a potential inhibitor against leptospirosis
  34. Identification of Potential Leptospira Phosphoheptose Isomerase Inhibitors Through Virtual High-Throughput Screening
  35. Analysis of binding properties of VP2 protein of Human parvovirus B19 through in silico molecular docking
  36. Functional annotation of human parvovirus b19 proteome and Molecular docking of VP1 protein with Teniposide
  37. Structural insight to Streptococcus mitis thymidylate kinase: a potential common drug target of infective endocarditis
  38. Envelope protein as molecular target for YFV (Yellow fever virus) drug discovery
  39. In Silico Analysis To Explore Novel Inhibitors For Human Proto-oncogene Tyrosine Protein Kinase Src
  40. DESIGNING POTENT INHIBITORS OF HUMAN p38γ FOR EFFECTIVE BREAST CANCER THERAPY
  41. LIGAND BASED VIRTUAL SCREENING TO DESIGN NOVEL HUMAN MEK1 PROTEIN INHIBITORS FOR POTENTIAL DEVELOPMENT OF DRUGS AGAINST MELANOMA
  42. Designing Novel Lead Molecules For Human Ribosomal Protein S6 Kinase Beta-1 Involved In Cancers: Ligand Based Virtual Screening Approach
  43. IDENTIFICATION OF POTENT LEADS FOR HUMAN cAMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA: A STRATEGIC APPLICATION OF VIRTUAL SCREENING FOR CANCER THERAPEUTICS
  44. COMPUTERIZED PROTEIN MODELING AND MOLECULAR DOCKING ANALYSIS OF HUMAN PROTO ONCOGENE TYROSINE PROTEIN KINASE YES FOR DISCOVERY OF NOVEL LEAD MOLECULES
  45. Designing Potent Inhibitors Of Human p38γ For Effective Breast Cancer Therapy
  46. IN SILICO ANALYSIS AND IDENTIFICATION OF POTENT INHIBITORS FOR HUMAN SERINE/THREONINE PROTEIN KINASE PIM-3 INVOLVED IN HEPATIC CANCER
  47. In silico identification of common putative drug targets in Leptospira interrogans
  48. Virtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligase
  49. Impact of nitrophenols on the photosynthetic electron transport chain and ATP content in Nostoc muscorum and Chlorella vulgaris
  50. Effect of three nitrophenols on carbon metabolism in Nostoc muscorum and Chlorella vulgaris
  51. Siderophore Production in Two Species of Nostoc as Influenced by the Toxicity of Nitrophenolics
  52. Effective Concentrations of Nitrophenolics Toward Growth Yield of Selected Microalgae and Cyanobacteria Isolated from Soil
  53. Biodegradation of methyl parathion by soil isolates of microalgae and cyanobacteria